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Abstract
Background
The immune mechanisms underlying experimental non-alcoholic steatohepatitis (NASH),
and more interestingly, the effect of T. cruzi chronic infection on the pathogenesis of this
metabolic disorder are not completely understood.
Methodology/Principal Findings
We evaluated immunological parameters in male C57BL/6 wild type and TLR4 deficient
mice fed with a standard, low fat diet, LFD (3% fat) as control group, or a medium fat diet,
MFD (14% fat) in order to induce NASH, or mice infected intraperitoneally with 100 blood-
derived trypomastigotes of Tulahuen strain and also fed with LFD (I+LFD) or MFD (I+MFD)
for 24 weeks. We demonstrated that MFD by itself was able to induce NASH in WTmice
and that parasitic infection induced marked metabolic changes with reduction of body
weight and steatosis revealed by histological studies. The I+MFD group also improved insu-
lin resistance, demonstrated by homeostasis model assessment of insulin resistance
(HOMA-IR) analysis; although parasitic infection increased the triglycerides and cholesterol
plasma levels. In addition, hepatic M1 inflammatory macrophages and cytotoxic T cells
showed intracellular inflammatory cytokines which were associated with high levels of IL6,
IFNγ and IL17 plasmatic cytokines and CCL2 chemokine. These findings correlated with an
increase in hepatic parasite load in I+MFD group demonstrated by qPCR assays. The re-
cruitment of hepatic B lymphocytes, NK and dendritic cells was enhanced by MFD, and it
was intensified by parasitic infection. These results were TLR4 signaling dependent. Flow
cytometry and confocal microscopy analysis demonstrated that the reactive oxygen species
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and peroxinitrites produced by liver inflammatory leukocytes of MFD group were also exac-
erbated by parasitic infection in our NASH model.
Conclusions
We highlight that a medium fat diet by itself is able to induce steatohepatitis. Our results
also suggest a synergic effect between damage associated with molecular patterns gener-
ated during NASH and parasitic infection, revealing an intense cross-talk between metaboli-
cally active tissues, such as the liver, and the immune system. Thus, T. cruzi infection must
be considered as an additional risk factor since exacerbates the inflammation and acceler-
ates the development of hepatic injury.
Author Summary
Chagas disease caused by the protozoan parasite T. cruzi is a neglected tropical disease
widespread in Latin America, and non-alcoholic steatohepatitis constitutes a prominent
health concern with increasing incidence of obesity and diabetes worldwide. Parasitic in-
fection induced marked metabolic changes, improved insulin resistance, but it increased
the triglycerides and cholesterol plasma levels. Our findings demonstrate for the first time
a synergic effect between the hepatic damage caused during the steatohepatitis process
(generated by a medium fat diet) and the exacerbated inflammation triggered by the
chronic parasitic infection, revealing an intense cross-talk between the liver, a metabolical-
ly active tissue, and the immune system. We propose that T. cruzi infection must be con-
sidered as an additional risk factor for this metabolic disorder. These findings may provide
new insight for the American Trypanosomiasis associated with the steatohepatitis.
Introduction
The liver is a key organ that controls the metabolic homeostasis of lipids, carbohydrates, and
proteins. Accumulative evidence demonstrates that the liver has specific immunological prop-
erties and contains a large number of resident and non-resident cells that participate in the reg-
ulation of inflammatory and immune responses [1,2]. The dysregulation of hepatic functions
could lead to metabolic disorders. Society worldwide has experienced a lifestyle shift towards
higher intake of fat food, chronic stress and less physical activity [3]. Fatty liver diseases are an
increasingly common cause of liver disease that can progress to non-alcoholic steatohepatitis
(NASH) and this constitutes a major health concern along with the increasing incidence of
obesity and diabetes in the world. It is estimated that it affects at least 30% of the general popu-
lation [4–7]. NASH is considered to be a chronic inflammatory liver disease influenced by
risk factors of the metabolic syndrome [8] and by the insulin resistance (IR) associated with
steatosis, overweight, dyslipidaemia, hyperinsulinaemia, and arterial hypertension [9]. But
this process is not well understood. Inflammation is imposed on steatosis by recruitment and
activation of inflammatory cells in the liver, which contributes to steatohepatitis [10]. This phe-
nomenon can be explained by increased lipolysis from the fat cells or increased intake of die-
tary fat, followed by the enrichment of free fatty acids (FFA). In addition, de novo lipogenesis
in the liver greatly contributes to hepatic steatosis. A cross-talk between different metabolically
active tissues and the immune system has been also proposed [11].
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In murine models of obesity induced by a high fat diet (HFD), macrophages switch to a
M1-polarization state [12,13]. This phenomenon appears to be associated with C-C chemokine
receptor 2 (CCR2)-dependent monocyte recruitment. Remarkably, the inhibition of MCP1/
CCL2 induces an improvement of steatohepatitis and metabolic syndrome [14]. In addition, an
imbalance of NK, DCs, B cells and different subtypes of T cells have been involved in steatohe-
patitis [15].
On the other hand, Trypanosoma cruzi is the protozoan parasite that causes Chagas dis-
ease, which is widespread in Latin America. It is estimated that 10 million people are infected
worldwide and more than 25 million people are at risk of the infection [16]. However, in the
past decades, mainly as a result of increased population migrations, the diagnosed cases
have increased also in non-endemic countries such as Canada, United States of America and
Europe [17]. Parasite persistence eventually results in severe complications in the cardiac
and gastrointestinal tissues. T. cruzi also infects the reticuloendothelial system including
liver, spleen, and bone marrow [18]. We have previously studied the innate immune re-
sponse and liver damage triggered by T. cruzi (Tulauhen strain) during acute infection in
mice [19].
Toll-like receptors (TLR) recognize pathogen-associated molecular patterns (PAMPs) but
also bind damage-associated molecular patterns (DAMPs), which are molecules released by
sterile injury. Thus, PAMPs and DAMPs that bind to the same type of receptor initiate similar
intracellular pathways terminating in identical effector functions, which play a crucial role in
the pathogen clearance as well as in the onset of steatohepatitis. Thus, different T. cruzi ligands
for TLR2 and TLR4, among others, have been identified [20]. Moreover, MyD88 KO mice
were more susceptible to the infection showing high parasitemia and mortality [21]. Our group
demonstrated for the first time a differential modulation in the expression of TLR2, TLR4 and
TLR9 in hepatocytes from infected mice. Furthermore, endogenous molecules produced by
dying cells, or in certain pathological conditions, such as excessive FFA, denatured host DNA
and oxidized low density lipoprotein (oxLDL), may stimulate TLRs resulting in the develop-
ment or acceleration of inflammatory diseases [22,23]. Although chronic stimulation of the in-
nate immune system is believed to underlie the pathology of these diseases, the molecular
mechanisms of activation remain unclear. Genetic deficiency of TLR4 or MyD88 is associated
with a significant reduction of hepatic injury in hypercholesterolemic mouse model, providing
a pathophysiologic link between innate immunity, inflammation, and steatohepatitis [24–27].
CD36 scavenger receptor was also involved in the development and progression of esteatohe-
patitis [28] as well as in atherosclerosis [29] promoting sterile inflammation through assembly
of a TLR4 and TLR6 heterodimer [30,31]. Even though there have been enough evidence of
these disorders, the understanding of the effect of T. cruzi infection on the pathogenesis of
these processes has been poorly explored [32].
In this work we focus on critical aspects of liver innate and adaptive immune cells, the TLR4
signaling, inflammatory cytokines and immune mechanisms underlying a chronic steatohepa-
titis experimental model and we also investigate how T. cruzi infection influences the evolution
of this metabolic disorder. We emphasize that medium fat diet by itself is able to induce steato-
hepatitis, but interestingly, the combination with this parasite infection induces marked meta-
bolic changes in the host, suggesting an intense synergism between the immune response
provoked by DAMPs raised as a consequence of the steatohepatitis and PAMPs of T. cruzi.
Our results demonstrates that an exacerbated inflammatory process induced by the infection
could be detrimental for the steatohepatitis. Moreover, this process correlated with higher he-
patic parasite load in I+MFD compared to the I+LFD group. These findings, may provide
novel avenues for therapeutic targets of NASH, the most common chronic liver disease in the
world associated with American Trypanosomiasis.
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Materials and Methods
Ethic statement
All animal experiments were approved by and conducted in accordance with guidelines of the
Committee for Animal Care and Use of the Facultad de Ciencias Químicas, Universidad
Nacional de Córdoba (Approval Number HCD 388/11) in strict accordance with the recom-
mendation of the Guide to the Care and Use of Experimental Animals published by the
Canadian Council on Animal Care (OLAW Assurance number A5802–01).
Mice and experimental design
C57BL/6J male mice were purchased from Facultad de Ciencias Veterinarias, Universidad
Nacional de La Plata, Argentina and C57BL/10ScNJ mice lacking the Tlr4 gene (Tlr4lps-del
mice) were from The Jackson Laboratory, Bar Harbor, ME, USA.
The mice were maintained under a standard light cycle (12 h light/dark) and were allowed
free access to water and food. Six-to-eight-week-old male mice were fed with a standard low fat
diet, LFD (3% from fat), or a medium fat diet, MFD (14% fat), or infected intra-peritoneally
with 100 blood-derived trypomastigotes of Tulahuén strain and also fed with LFD (I+LFD) or
MFD (I+MFD) for 24 weeks. LFD composition: 26% protein, 53% carbohydrate, 3% fat, 8%
crude fiber and 10% total mineral; MFD composition: 25% protein, 50% carbohydrate, 14% fat,
3% crude fiber and 8% total mineral.
Infection was corroborated with the ELISA Chagas test (Wiener). Titles of IgG antibodies
anti-T.cruzi higher than 1/1024 were detected at 24 weeks. Parasites were maintained by serial
passages in mice. Parasitemia was monitored by counting the number of viable trypomastigotes
in blood collected from the retrorbital sinus after lysis with a 0.87% ammonium chloride buffer.
All animals were weighed, anesthetized with isofluorane and were sacrificed before liver
tissue collection.
Measurement of plasma lipids
After 4, 12 and 24 weeks, the mice were fasted for 10 hours, and blood samples were collected.
Plasma total cholesterol (TC) and triglyceride (TG) concentrations were quantified with the
use of enzymatic kits (Roche) in a Hitachi modular P800 autoanalyzer.
Determination of homeostasis model assessment of insulin resistance
The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated using the
following formula: fasting blood glucose (mg/dl) × fasting insulin (μU/ml)/405. Plasma insulin
levels were measured with an insulin RIA kit DPC Coat A Count (Siemens) using Ingetron
MODEL MN2200-E. Plasma glucose levels were measured using an enzymatic kit (Roche)
with Hitachi modular P800.
Cytokine assays
The ELISA sandwich assay was performed for quantification of cytokine and chemokines
levels. Briefly, ELISA plates were coated with anti-cytokine/chemokine antibodies (BD Phar-
mingen and e-Bioscience) overnight and then washed and blocked. The plasma obtained at
24 weeks was incubated overnight. After that, plates were subjected to biotinylated anti-
cytokine/chemokine antibody (BD Pharmingen and e-Bioscience) for 1 h. After washing, the
plates were incubated with streptavidin–peroxidase (BD Pharmingen), and washed once more.
The reaction was revealed using TMB Substrate Chromogen (BD Pharmingen), before being
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read at 450 nm in a Microplate reader (Bio-Rad). Standard curves were generated using recom-
binant cytokines (BD Pharmingen and e-Bioscience).
Histological analysis
Mice were euthanized and slowly perfused by intracardiac injection with 10 ml of heparin
diluted in PBS after 10-h fast. Liver tissue was collected and samples were fixed with 10% PBS-
formaldehyde and embedded in paraffin. Tissue sections were cut at a thickness of 5 μm and
stained with hematoxylin and eosin (H&E). TG accumulation in the liver was examined by
Sudan Black IV staining. Liver specimens were then evaluated by light microscopy using a
Nikon Eclipse TE 2000 U equipped with a digital video camera.
Measurement of TG and total cholesterol in the liver
Liver tissues were homogenized with PBS using a hand homogenizer. Homogenates were
centrifuged at 5000 rpm for 10 min at 4°C. The supernatant was then collected and TG and
cholesterol were determined using commercial enzymatic kits (Roche) in a Hitachi modular
P800 auto-analyzer.
Isolation of mouse intrahepatic leukocytes
Intrahepatic leukocytes (IHLs) were isolated from all mouse groups as previously described
[33]. Briefly, liver in RMPI medium containing gentamicin (both from Gibco) plus 1% of FBS
(Sigma-Aldrich) was passed through 100-mm nylon meshes; red blood cells were removed
using lysis buffer (Sigma) and finally IHLs were obtained after 20 min centrifugation (600 × g)
in a 35% and 70% bilayer Percoll (Sigma) gradient. Viable cells number was determined by
Trypan blue exclusion.
Flow cytometry
One million cells were washed in ice-cold FACS buffer (PBS-2% FBS) and incubated with
fluorochrome labeled-Abs for 20 min at 4°C. Different combinations of the following Abs
were used: 1) PE-labeled: anti- CD36, F4/80 or CD19; 2) APC or Alexa Fluor 647-labeled: anti-
CD11c, NK1.1 or CD4; 3) PECy7-labeled: anti-F4/80; 4) PerCPCy5.5-labeled: anti- CD4 or
CD3; 5) FITC-labeled: anti-CD3 or CD68; 6) biotin-labeled: anti-CD206 and SA-PEcy5. Intra-
cellular cytokines were detected after stimulating cells during 5 hours with 30 ng/ml PMA and
500 ng/ml ionomycin (Sigma), in the presence of GolgiStop and brefeldin (BD Biosciences).
Cells were surface-stained, fixed and permeabilized with BD Cytofix/Cytoperm and Perm/
Wash (BD Biosciences) according to the manufacturer's instruction. Cells were incubated
with PE-labeled antibody to IFNγ, IL-17F and CCL2; PECy7-labeled antibody to IL-10 (BD
Biosciences), PerCPCy5.5-labeled anti- TNFα and CCL3. Detection of Ab FITC-labeled anti-
CD107a (BioLegend) [34] were performed as previously described. Oxidation-sensitive dye
H2DCFDA (Molecular Probes, Invitrogen), was used to measure ROS production [35]. Cells
were acquired on FACSCanto II (BD Bioscience).
Confocal microscopy
IHL were cultured in 24 wells on glass coverslips with ConA for 48 h, fixed in 4% paraformal-
dehyde, blocked with PBS-BSA 1% and labeled with FITC-anti mouse-CD3 and Alexa Fluor
647-anti- nitro tyrosine (NT), FITC-anti F4/80, rabbit anti- mouse-p47phox and then incubated
with Alexa Fluor 555- anti-rabbit. DNA was stained with DNA-binding fluorochrome Hoechst
33258 (2 ug/mL). Slides were observed with a FV1000 (Olympus) confocal microscope.
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q-PCR assays
DNA was isolated from 50 mg of hepatic tissue from I+LFD and I+MFD animals at 24 weeks
of treatment using an AccuPrep Genomic DNA Extraction Kit (BIONNER), according to the
manufacturer's protocol. Samples were stored at-80°C. The quantity and purity of the DNA
were determined with the spectrophotometer Synergy HTMulti-Mode Microplate Reader
(Biotek), and only samples with high purity were used in the experiments. 200 ng DNA were
amplified by q-PCR using Power SYBR Green PCRMaster Mix 2x (Applied Biosystems, Life
Technologies) and specific primers for a T. cruzi satellite sequence. As an endogenous control,
eEF2 primers were used [36]. Each primer pair was tested to reach the appropriate conditions
of amplification. The primer sequence used were: Tcz1 (S: 5´-CGA GCT CTT GCC CAC ACG
GGT GCT-3´ and Tcz2 (AS: 5´-CCT CCA AGC AGC GGA TAG TTC AGG-3´) [37]; and
eEF2 (S: 5´-AAG CTG ATC GAG AAG CTG GA-3´ and AS: 5´-CCC CTC GTA TAG CAG
CTC AC-3´).
Briefly, we amplified a 195pb TCZ satellite sequence using a initial denaturation step for
95°C for 10 min following of 40 PCR cycles with a denaturation temperature of 95°C for 15 s,
an annealing and extension temperature of 60°C for 1 min, and a melting curve on a 7500 Real
Time PCR System (Applied Biosystems). The internal standard eEF2 (186pb) was amplified
with the same thermoprofile.
All DNA extractions and amplification reactions were performed with the appropriate nega-
tive controls to detect contamination at any stage of the procedure and with positive controls that
gave reproducible results during all of the experiments and each sample was run by triplicate.
To determine levels of gene expression TCZ we used the comparative Ct method, known as
2-ΔΔCT method [38].
Statistical analysis
To compare different experimental conditions, analysis of variance (two-way or one-way
ANOVA) along with Bonferroni's post test were performed using GraphPad software. A two-
tailed Student' t-test was used for comparison between control and experimental samples. A
p-value<0.05 was considered significant.
Results
T. cruzi infection reduces body weight, improves insulin resistance and
increases the plasma triglyceride and cholesterol levels
First, we analyzed biochemical and metabolic parameters of the experimental groups (LFD,
MFD, I+LFD and I+MFD) in C57BL/6J WT and TLR4-/- mice. The WT group fed MFD had
significantly higher body weight (43.5 ± 2.3 g) than LFD group (34± 1.0 g). Conversely, this in-
crease on body weight was not observed in MFD TLR4-/- mice (33.7 ± 2.9 g). Notably, the
weight due to MFD in WTmice was significantly reduced by the parasite infection (I+MFD)
(32.4±3.7 g) (Fig. 1A). Next, we focused on the study of plasma glucose and insulin levels in
all mice groups until 24 weeks of treatment. The (HOMA-IR) index, as an assessment of insu-
lin resistance, is shown in Fig. 1B. This parameter was significantly increased in the MFD
WT group (approximately 4 times higher than the LFD group) and remained elevated until
24 weeks. In the I+MFDWT group, this index increased early (4 weeks) but at the end of
the study (24 weeks), was reduced compared to the MFDWT group. Noteworthy, only the
MFD TLR4-/- group showed an increase of HOMA-IR at 12 weeks, although the values were
similar for all TLR4-/- groups at the end of the study. The plasma triglyceride concentration in
the MFDWT group was significantly higher than the LFDWT and I+MFDWT groups at
Trypanosoma cruzi and Non-alcoholic Steatohepatitis
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Figure 1. Metabolic abnormalities associated with diet-induced overweight and infection with T. cruzi.
Metabolic parameters were measured after a 10-h fasting in mice on either MFD, LFD, I+MFD or I+LFD
groups of WT and TLR4-/- mice at 4, 12 or 24 weeks, including: (A) Body weight ***p< 0.001 MFD vs. LFD
at 4 and 24 weeks in WT; LFD vs. I+LFD **p< 0.01 at 12 and 24 weeksWT and ***p< 0.001 MFD vs.
I+MFD at 24 weeks in WT. (B) Changes in plasma HOMA-IR in WTmice: **p< 0.01 MFD vs. LFD at 4
weeks, **p< 0.01 I+LFD vs. I+MFD at 4 weeks and MFD vs. LFD at 24 weeks, *p< 0.05 MFD vs. LFD at
12 weeks; Changes in plasma HOMA-IR in TLR4-/- mice: *p< 0.05 LFD vs. I+LFD at 4 weeks, ***p< 0.001
Trypanosoma cruzi and Non-alcoholic Steatohepatitis
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4 weeks. At 24 weeks, the triglyceride level was increased in all groups vs. the LFDWT. In con-
trast, there were no significant changes in triglyceride levels throughout the study in TLR4-/-
groups (Fig. 1C). The mean values of plasma cholesterol at 4, 12 and 24 weeks from each group
are presented in Fig. 1D. The highest cholesterol concentration was found in the I+MFDWT
group at all studied time point. Later, at 24 weeks, cholesterol level was increased in all groups
vs. the LFDWT group. In contrast, only I+MFD TLR4-/- group showed elevated cholesterol
levels at 24 weeks compared to MFD TLR4-/- (Fig. 1D). To further analyze the lipoprotein dis-
tribution in plasma, the latter was submitted to agarose gel electrophoresis. In TLR4-/- mice,
the lipoprotein pattern did not change among the groups, but an augmentation of LDL was
noted in MFDWTmice at 24 weeks (S1 Fig.).
The MFD and LFD groups did not exhibit any clinical signs of illness during the entire ex-
perimental period, although the MFD group exhibited oily hair at 4 and 12 weeks. The I+LFD
group displayed signs of illness such as squinting eyes, ruffled fur, reduced motility and appe-
tite during the period of high parasitemia. In the chronic phase the clinical signs were more dif-
fuse except for the loss of weight. In the I+MFD group these symptoms were more pronounced
and appeared earlier, from day 20 dpi until the end of the experimental period.
T. cruzi infection reduces the steatosis but enhances the hepatic
inflammation
In the liver, the intake of MFD for 24 weeks produced lipid micro/macro vesicles and inflam-
matory foci, compatible with steatohepatitis only in WT mice. These morphological changes
were not seen neither in the LFDWT fed mice nor in TLR4-/- groups. Notably, in the I+MFD
WT or TLR4-/- group, we did not observe ectopic fat depots (Fig. 2A). These results were
associated with high levels of hepatic triglyceride and cholesterol in the MFDWT group.
However, the infection enhanced cholesterol accumulation in the liver (Fig. 2B). We did not
found significant changes in hepatic triglyceride and cholesterol values between the different
TLR4-/- groups (S2 Fig.). In addition, IHLs were found in both WT or TLR4-/- infected
groups. This observation was further confirmed by hepatic leukocyte count (Fig. 2C).
Parasite infection enhances the M1 inflammatory macrophage profile
and CD36 expression
It is widely known that F4/80+ cells play a critical role in liver inflammation. We found an in-
creased F4/80+ cell number in MFD vs. LFDWT group at 24 weeks, whereas, the number of
hepatic macrophage did not change in the MFD TLR4-/- group. However, the parasite infec-
tion increased the F4/80+ cell number in both WT and TLR4-/- groups. Moreover, increased
absolute cell number and percentage of F4/80+CD206-CD68+ (Classical M1 macrophage polar-
ization) were observed in experimental WT groups and infected TLR4-/-. The absolute number
of F4/80+CD206+CD68- cells (Alternative M2 macrophage polarization) was similar among
the different WT groups although the percentages diminished in all groups vs. LFDWT
(Fig. 3A and S3 Fig.). Conversely, the MFD TLR4-/- mice did not show any differences in the
MFD vs. LFD, I+LFD and I+MFD at 12 weeks. (C) Plasma triglycerides concentrations in WTmice:
***p< 0.001 MFD vs. LFD at 4 weeks, **p< 0.01 MFD vs. I+MFD at 4 weeks. (D) Plasma cholesterol
concentrations in WTmice: ***p< 0.001 I+LFD vs. I+MFD at 4 weeks; **p< 0.01 MFD vs. LFD and I+LFD
vs. I+MFD at 12 weeks; ***p< 0.001 MFD vs. LFD at 24 weeks, *p< 0.05 LFD vs. I+LFD at 24 weeks and
**p< 0.01 I+LFD vs. I+MFD at 24 weeks. The analysis in TLR4-/- groups: *p< 0.05 I+LFD vs. I+MFD and
MFD vs. I+MFD at 24 weeks. n> 10 for each mice group were analyzed at all times studied. Data are shown
as mean ± SEM of a representative assay from three independent experiments. A p-value<0.05 was
considered significant using Two-way ANOVA test.
doi:10.1371/journal.pntd.0003464.g001
Trypanosoma cruzi and Non-alcoholic Steatohepatitis
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003464 February 10, 2015 8 / 22
number of M1 cells vs. LFD TLR4-/- mice (Fig. 3A). In order to better characterize the macro-
phage population, we also included CD11c marker to discriminate F4/80+CD206-CD11c+ (M1)
and F4/80+CD206+CD11c- (M2) macrophages with similar results to those described above
(S4 Fig.). In addition, we observed a high frequency of F4/80+CD11c+TNFα+ cells in all WT
groups vs. the LFDWT (S4 Fig.).
CD36 has been highly implicated in the metabolic inflammatory disease [28,29], hence, we
analyzed the expression pattern of this scavenger receptor on F4/80+ cells. We observed an
increased CD36 expression in all WT groups with the highest values in I+MFD and I+LFD
groups. We did not observe any changes when compared MFD vs. LFD TLR4-/- mice however,
infected TLR4-/- groups showed augmented CD36 expression on F4/80+ cells (Fig. 3B). Addi-
tionally, we detected a significant fold increase of CCL3/MIP-1α and CCL2/MCP-1 producing
F4/80+ cells only in the WT strain fed with MFD (Fig. 3C).
Figure 2. Hepatic inflammation and steatosis in WT and TLR4-/- mice with or without T. cruzi infection. (A) Liver tissue from all groups was subjected
to hematoxylin and eosin (H&E at 400x) and Sudan Black IV staining (A, Insert) The arrows represent inflammatory foci. Scale bar = 20 μm. (B)Hepatic
triglyceride and cholesterol contents were determined and expressed as mg/g of liver tissue of WT groups. (C) The numbers of IHLs were similar in mice of
both genotypes with infection but the degree of steatohepatitis was significantly higher in MFD vs. LFDWTmice (*p< 0.05). All results are shown at 24
weeks of treatment and were representative of at least three independent experiments. Data are shown as mean ± SEM of more than 4 mice per group.
doi:10.1371/journal.pntd.0003464.g002
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T. cruzi infection exacerbates the local T cell response induced by MFD
Next, we analyzed the total number of CD3+ cells and CD4+/CD8+ subpopulations in the liver
of WT mice at 24 weeks. We observed a high number of T cells in all experimental groups with
the highest values in I+MFD group (Fig. 4A). The MFDWT group increased CD3+CD8+ cell
number, and more prominently the infected groups (Fig. 4B). To better characterize the sub-
type of T helper cells we analyzed the production of IFNγ/TNFα and IL-17 (Th1 and Th17
respectively) or IL10 (Th2 phenotype). We observed a high number of IFNγ-producing CD4+
T cells in all experimental groups vs. LFDWT, as it is shows in Fig. 4C. Surprisingly, our results
revealed a strong increment of TNFα (Fig. 4C) and IL17- producing T cells only in the MFD
WT group (Fig. 4D). In addition, CD4+ IL10+ T cells were significantly increased in the MFD
WT group (Fig. 4E). Regarding CCL2 and CCL3, two important chemokines for recruitment
and activation of monocytes/macrophages, we found a significant increase of CCL2- and
CCL3-producing T cells only in MFDWT group (Fig. 4F). Strikingly, TLR4-/- mice did not re-
veal any difference between the MFD and LFD groups (S5 Fig.). Finally, we observed intracellu-
lar staining for IFNγ and TNFα in CD8+CD107+ T cells in all WT groups as shown in Fig. 4G.
Figure 3. Expression of M1/M2markers and CD36 expression fromWT and TLR4-/- mouse liver macrophages. IHLs from all groups of mice were
purified at 24 weeks and then stained with anti-F4/80, anti-CD206 anti-CD68 Abs. (A) The absolute number of F4/80+ cells of phenotype M1 (CD206-CD68+)
and M2 (CD206+CD68-) are indicated. (B) The CD36 expression, after gating on F4/80 is showed. (C) Fold increase of percentages of CCL2- and CCL3-
producing F4/80+ cells in liver of WT and TLR4-/- respect to LFD group. Cells were gated on F4/80 vs. side scatter dot plots. These assays were performed
by flow cytometry and shown as mean ± SEM of six mice from one experiment representative of four performed.
doi:10.1371/journal.pntd.0003464.g003
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Figure 4. The local T cell response is induced by MFD and exacerbated by T. cruzi infection. IHLs from different groups of mice obtained at 24 weeks
were stained with anti-CD3, anti-CD4, anti-CD8, anti-TNFα, anti-IFNγ, anti-IL17, anti-IL10, anti-CCL2, anti-CCL3 and anti-CD107 Abs. (A) The absolute
numbers of CD3+ and (B) the absolute numbers of CD3+CD4+ and CD3+CD8+ cells in liver are indicated. (C) Percentage of TNFα and IFNγ producing CD4+
T cells in liver of WT are shown by intracellular staining. Percentage of (D) IL17 and (E) IL10 producing CD4+ T cells in liver of WT are shown by intracellular
staining. (F) Percentages of CCL2 and CCL3 producing CD3+ T cells in liver of WT are shown by intracellular staining. (G) Percentages of CD107a+CD8+ T
cells. IHLs from all groups were cultured in the presence of PMA plus ionomycin and monensin for 5 h and stained with corresponding antibodies. Data are
shown as mean ± SEM of more than 4 mice per group from one experiment representative of three performed.
doi:10.1371/journal.pntd.0003464.g004
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Remarkably, the MFD group showed an elevated number of TNFα+ and IFNγ+ double positive
cells while infected groups showed an increased number of IFNγ+ single positive and TNFα+
and IFNγ+ double positive cells compared to the LFDWT group.
The recruitment of B lymphocytes, NK and dendritic cells in liver is
induced by MFD and is exacerbated by parasite infection
We also found a high number of CD19+, CD11c+ high, and NK1.1+CD3- (NK) cells in liver of
MFDWTmice (Fig. 5A-C). The increment of these cell populations was more pronounced in
infected mice (I+LFD or I+MFDWT groups). On the other hand, NK1.1+CD3+ (NKT) cells
were increased in infected groups but not in MFDWTmice. In addition, IFNγ-producing NK
cells from all experimental WT groups showed a CD107+ activated phenotype compared with
the LFDWT group (Fig. 5D). Notably, we did not observe any difference in MFD TLR4-/-
mice, demonstrating the key role of TLR4 in our steatohepatitis model. However, the infected
TLR4-/- groups showed an increased number of these cell populations (S6 Fig.).
The outburst of systemic inflammatory cytokines is highly dependent on
TLR4 signaling
Lipid accumulations, their subsequent lipotoxicity and parasite infection trigger intracellular
signaling pathways, which lead to the production of pro-inflammatory cytokines and
Figure 5. The recruitment of B lymphocytes, dendritic cells and NK cells in liver is induced by MFD and increased by parasite infection. IHLs from
different groups of mice were stained with anti-CD19, anti-CD11c, anti-CD3, anti-NK1.1, anti-CD107 and anti-IFNγ. (A) The absolute numbers of CD19+, (B)
the absolute number of CD11chi in liver and (C) the absolute number of NK and NKT cells are indicated. (D) Percentage of CD3- NK1.1+ CD107a+ cells. IHLs
from all groups were cultured in the presence of PMA plus ionomycin and monensin for 5 h and stained with corresponding antibodies. Data are shown as
mean ± SEM of more than 4 mice per group from one experiment representative of three performed.
doi:10.1371/journal.pntd.0003464.g005
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chemokines and are responsible for cellular recruitment. In our model, we detected high levels
of plasmatic IL6, IL17, IFNγ cytokines and the CCL2 chemokine in all experimental WT
groups vs. LFD at 24 weeks; the highest levels of IL6 and IFNγ were observed in I+MFD vs.
MFDWT (about 100 fold increase). In addition, the IL10 anti-inflammatory cytokine was only
detected in the plasma of the MFDWT (Fig. 6A). The concentrations of inflammatory cyto-
kines were very low in plasma of infected TLR4-/- mice in comparison with their respective
control WT groups, as shown in Fig. 6B. Likewise, the MFD TLR4-/- group did not show dif-
ferences compared to the LFD TLR4-/- group.
Parasite infection exacerbates reactive oxygen species and
peroxinitrites production by liver inflammatory leukocytes in MFD group
Taking into account the key role of macrophages and T lymphocytes during steatohepatitis, we
first evaluated the ROS production by liver- infiltrating F4/80+ and Gr1+ cells by comparing
their H2DCFDA fluorescent signals. Increased amount of ROS were produced in all experi-
mental groups compared with the LFDWT as shown by their respective histograms (Fig. 7A).
Moreover, an increased expression of cytoplasmic p47phox, a subunit of NADPH oxidase com-
plex, was observed (Fig. 7B). We also demonstrated a high expression of tyrosine nitration on
Figure 6. The outburst of systemic inflammatory cytokines is highly dependent on TLR4 signaling
and increased by parasite infection. The cytokine production was quantified by ELISA in plasma collected
from all groups of mice at 24 weeks of treatment with LFD, MFD, I+LFD or I+MFD. (A)WTCCL2: **p< 0.01
MFD vs. LFD and *p< 0.05 I+LFD vs. LFD; IL6: *p< 0.05 MFD vs. LFD, **p< 0.01 I+LFD vs. LFD,
***p< 0.001 MFD vs. I+MFD and **p< 0.01 I+LFD vs. I+MFD; IFNγ: *p< 0.05 MFD vs. LFD, **p< 0.01 I
+LFD vs. LFD, **p< 0.01 MFD vs. I+MFD and *p< 0.05 I+LFD vs. I+MFD; IL17: **p< 0.01 MFD vs. LFD,
**p< 0.01 I+LFD vs. LFD, ***p< 0.001 MFD vs. I+MFD and *p< 0.05 I+LFD vs. I+MFD. (B) TLR4-/-
CCL2: *p< 0.05 I+LFD vs. LFD; IFNγ: *p< 0.05 MFD vs. I+MFD; IL17: **p< 0.01 I+LFD vs. LFD and
***p< 0.001 MFD vs. I+MFD. All data are shown as mean ± SEM of four to eight mice per group from one
experiment representative of two performed. A p-value<0.05 was considered significant using Two-way
ANOVA test.
doi:10.1371/journal.pntd.0003464.g006
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T-cell surface (Fig. 7C). Furthermore, protein tyrosine nitration occurred in hepatic tissue of
I+MFDWT group was noted suggesting that peroxynitrite radicals or derivatives may contrib-
ute to hepatic injury. These results were associated with a high expression of FasL on hepatic
CD3+ cells from all experimental groups compared with LFD group (S7 Fig.).
Figure 7. Reactive oxygen species and peroxinitrites are produced by liver inflammatory leukocytes induced by MFD and exacerbated by parasite
infection. (A) IHLs from all groupsWT were stimulated with PMA (30 mg/mL) and incubated with H2DCDFA (10uM) for 30 minutes at 37°C and Intrahepatic
cells were then stained with anti-Gr-1, anti-F4/80. The percentage of ROS in Gr-1+ and F4/80+ cells was measured by flow cytometry and the results are
shown as mean ± SEM of six mice from one experiment representative of two performed. Statistical significance determined by one-way ANOVA test. (B)
Expression of p47phox in F4/80+ cells. IHLs from different groups of mice were stimulated with Con A 48h and then stained with anti-F4/80 FITC, anti-p47phox/
Alexa Fluor 555 Abs and then visualized using confocal microscopy. (C) Expression of tyrosine nitration in CD3+ T cells. IHLs from different groups of mice
were stimulated with Con A 48h and then stained with anti-CD3 FITC and anti-TN/Alexa Fluor 647 Abs, and visualized using a FV300 Olympus confocal
microscope. Scale bar = 10 μm.
doi:10.1371/journal.pntd.0003464.g007
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Medium-fat diet leads to increased parasite load in the liver
Given the strong inflammatory response at local and systemic level found in I+MFD group we
investigated whether the parasitemia and/or hepatic parasite load were influenced by the type
of diet. The parasitemia was detected until 38 days post-infection, and was higher in I+MFD
than in I+LFD group (Fig. 8A). Given that the parasitemia was undetectable at the chronic
phase, we determined by q-PCR T. cruzi DNA in livers of infected groups. The parasite load
was higher in I+MFD than I+LFD animals (Fig. 8B). These observations revealed that the diet
is a key factor in the liver parasite burden and hepatic injury.
Discussion
It is well known that IR commonly coexists with obesity, hypertension, hyperglycemia and dys-
lipidemia involving elevated triglycerides, small dense low-density lipoprotein particles, and
decreased HDL cholesterol levels. However, causal links between IR, obesity, and dietary fac-
tors are complex and controversial. High plasma insulin and glucose levels due to IR are the
major components of the metabolic syndrome [39]. Our results demonstrate that a medium fat
diet alone is able to induce weight gain and IR. The highest HOMA-IR values were detected in
the MFD group at 4 weeks and remained elevated until 24 weeks. As a result of IR, increased
hepatic and plasma triglycerides and plasma LDL levels were also detected in the MFD group
(Supl.1). In this sense, it was reported that high TNFα concentrations increased plasma triglyc-
erides levels by stimulating hepatic lipid secretion [40]. Besides, this cytokine is characterized
by possessing elevated lypolitic activity in adipocytes and by making body tissues more resis-
tant to the effects of insulin in different disease states [41,42]. Interestingly, this parasite may
persist in adipose tissue of humans and mice and become a reservoir of infection [43]. Our re-
sults clearly demonstrate that parasite infection induced marked metabolic changes such as a
reduction of HOMA-IR and fat accumulation in hepatic tissue with marked decrease in hepatic
triglyceride content at 24 weeks. Recently, Tanowitz's group described that T. cruzi Brazil strain
Figure 8. Medium-fat diet leads to increased parasitemia and parasite load in the liver. (A) Parasitemia
was determined at different time post T. cruzi infection in I+LFD and I+MFDWTmice, n = 10 per group. (B)
Quantitative assessment of the parasite load by q-PCR in the liver of infected groups. Parasite quantification
in DNA samples of I+LFD and I+MFD groups was performed amplifying a TCZ T. cruzi satellite sequence at
24 weeks post treatment. The relative load of parasites/liver was normalized against the eEF2 housekeeping
gene control. Two positive samples, two negative samples and non-template DNA were included in every q-
PCR. All data are shown as mean ± SEM of four mice per group from one experiment representative of two
performed. A p<0.05 was considered significant using two-tailed T test.
doi:10.1371/journal.pntd.0003464.g008
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infection induced glucose homeostasis changes, pancreatic inflammation and parasitism within
pancreatic β cells [44] but the effect of the Tulahuen strain in the pancreas is yet unknown. Al-
ternatively, the parasite could require host lipoproteins in order to multiply inside of cells [45].
Moreover, parasite-derived lipid metabolizing enzymes could play a variety of roles during in-
vasion, survival, establishment and exacerbation of the disease [46]. Noteworthy, we observed
that the liver remained a prominent reservoir of parasites at the chronic stage, at 24 weeks
post-infection. Several observations suggest that T. cruzi take advantage from host cell metabo-
lism that favors fatty acid oxidation over glucose oxidation [45]. Moreover, proteomic evidence
shows that T. cruzi upregulates the ability for fatty acid uptake and oxidization, suggesting a
coupling of parasite growth to fatty acid metabolism in the host [47]. Interestingly, we also
observed that the increase in body weight due to a MFD was suppressed by parasite infection
(I+MFD) at 12 and 24 weeks concordantly with the results reported by other researchers [32].
Besides, the blood triglyceride levels were also diminished by the infection at 4 weeks compared
with its respective control (MFD group). Strikingly, the infection or MFD or the combination
of both variables (I+MFD) increased the plasmatic and hepatic cholesterol concentrations. In
this sense, it was postulated that the T. cruzi infection induced changes in intracellular choles-
terol homeostasis, since it was reported an accumulation of LDL and cholesterol in tissues dur-
ing both acute and chronic infection [48]. It was also demonstrated that this parasite may use
the LDL receptor for cell invasion [49]. As expected, the MFD TLR4-/- group showed minor
metabolic changes compared to the MFDWT group without changes in body weight [26,50].
Notably, the infection was able to increase plasmatic cholesterol levels in MFD TLR4-/- mice at
a later time (24 weeks).
On the other hand, our results were consistent in demonstrating that the combination of
T. cruzi infection with MFD induced more liver inflammation in WT than in TLR4-/- mice.
Low systemic cytokine levels and reduced number of intrahepatic leukocytes were observed in
TLR4-/- groups. The pro-inflammatory cytokines may disrupt normal insulin action in fat and
muscle tissue and could be a major factor in causing the IR. Furthermore, it is known that fatty
liver may be more susceptible to injury because of leukocyte infiltration. Our results demon-
strate a predominant M1 F4/80+ cell accumulation in the liver from the MFD group only in
WT mice suggesting that inflammatory macrophage polarization is dependent on TLR4 signal-
ing. Strikingly, parasite infection markedly enhanced this phenomenon in two mouse strains
(WT and TLR4-/-). Thus, the combination of T. cruzi infection with fat diet (I+MFD) exacer-
bated M1 profile (F4/80+CD11c+TNFα+) in WT mice (S2 Fig.). The recruitment of these cells
in NASH was consistent with the high levels of CCL2 and CCL3 chemokines in liver and
blood, as detected by us and others [51,52]. Numerous evidence indicates that TNFα, CCL2
and CCL3 are also produced during the course of T. cruzi infection [53,54], which could ex-
plain the great recruitment of inflammatory cells into the hepatic tissue.
Interestingly, we detected an increase of CD36 scavenger receptor on hepatic F4/80+ cells
of the MFDWT group and even more of infected groups. Since, members of the CD36 scaven-
ger receptor family have been implicated as sensors of microbial products that mediate phago-
cytosis and inflammation; we speculated that T. cruzi PAMPs could directly interact with this
receptor. The presence of a lipoprotein scavenger-like receptor in the parasite cannot be dis-
carded and this mechanism could also explain the reduction of fat accumulation in the liver
of I+MFD vs. MFDWT groups. Furthermore, our data unequivocally show that IHL such as
B lymphocytes, DCs and IFNγ+-producing activated cytotoxic T cells and NK were increased
during the progression of steatohepatitis in the MFD group and notably, the parasite infection
had a remarkable synergistic effect in this process (24 weeks).
On the other hand, IL10-producing T lymphocytes, likely Th2 and/or T regulatory infiltrat-
ing liver, and plasma IL10, were only detected in the MFDWT group. The protective role of
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IL10 in IR may be involved in this step of steatohepatitis, balancing the effect of pro-inflamma-
tory cytokines. Conversely, in the I+MFD group, this cytokine was not detected, indicating that
the parasite infection produced a marked deregulation of this anti-inflammatory mechanism
[55]. In turn, high circulating levels of pro-inflammatory cytokines were detected in MFDWT
mice as well as in obese subjects [56] which may contribute to IR and to low-grade systemic
inflammation. It is also known that pro-inflammatory cytokines play an important role in con-
trolling the parasite replication [57]. As expected, TNFα, IL6 and IFNγ cytokines were en-
hanced by the infection, which have been associated with the progression of hepatic [18] and
cardiac injury [58]. The inflammatory cytokine profiles were more attenuated in TLR4-/-
groups, either in the physiological steatohepatitis model alone or in combination with T. cruzi
infection. The IL6 role in NASH is controversial since it was postulated that is a key factor in
the progression of this disease and the development of IR [59] and other researchers have as-
sumed that IL6 may limit endotoxemia and obesity-associated IR [60]. We claimed that the
strong IL6 production found in this model would appear limiting the development of IR. In
addition, in a similar way that occurs in humans, we found an increased number of IL17 -pro-
ducing CD4 T cells in the MFDWT group, although other sources of IL17 like γδ T or NKT
cells could be involved. Furthermore, IL-17 and FFAs synergize to produce IL6 by hepatocytes
[61] and IL17/IL17RA signaling is essential for controlling T. cruzi infection [62]. However,
IL-17 signaling accelerates the progression of NASH in mice [63]. Thus, this study demon-
strates for the first time a synergistic role of IL-17 in steatohepatitis associated with
this infection.
An intense cross-talk between hepatocytes, leukocytes and cytokines, added to oxidative
stress and apoptosis, are key actors in the steatohepatitis pathogenesis [64]. In this scenario,
our results demonstrated an increased ROS production by liver macrophages with tyrosine
nitrated proteins and an enhanced FasL expression on T-cell surface, which may induce apo-
ptosis of hepatocytes. Interestingly, the parasite infection exacerbated oxidative stress in our
NASH model.
Taken together, these findings highlight the contribution of our laboratory in understanding
how T. cruzi infection is able to diminish triglycerides accumulation in liver, while at the same
time, exacerbates the inflammatory process in a physiological NASH model. New tools that in-
tegrate current knowledge of steatohepatitis with American Trypanosomiasis pathogenesis
must be considered in the future.
Supporting Information
S1 Fig. Plasma lipoprotein distribution of WT and TLR4-/- mice induced by diet or/and
T. cruzi infection. Lipoprotein distribution were assessed at 24 weeks by agarose gel electro-
phoresis, after a 10-h fasting in mice on either LFD, MFD, I+LFD or I+MFD groups WT and
TLR4-/- mice.
(TIF)
S2 Fig. Hepatic triglyceride and cholesterol contents were similar among different TLR4-/-
groups.Hepatic triglyceride and cholesterol contents were determined and expressed as mg/g
of liver tissue in TLR4-/- groups. The results are shown at 24 weeks of treatment and were rep-
resentative of at least three independent experiments. Data are shown as mean ± SEM of more
than 3 mice per group.
(TIF)
S3 Fig. Shift of macrophage phenotype in experimental WT groups. Percentages of hepatic
F4/80+ cells of phenotype M1 (CD206-CD68+) and M2 (CD206+CD68-) are indicated. Data
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are shown as mean ± SEM of more than 3 mice per group from one experiment representative
of three performed.
(TIF)
S4 Fig. Frequency of F4/80+ CD11c+ macrophages (M1) positively stained for TNFα in
different WT groups. IHLs obtained at 24 weeks were stained with anti-F4/80, anti-CD11c,
anti CD206 and anti-TNFα. (A) Percentage of F4/80+ CD206- CD11c+ cells of different groups
of WT mice at 24 weeks is indicated. (B) IHLs from all groups were cultured in the presence of
PMA plus ionomycin and brefeldin for 5 h and stained with anti-F4/80, anti-CD11c and anti-
TNFα. A representative graphic is shown. Data are shown as mean ± SEM of more than 4 mice
per group from one experiment representative of three performed.
(TIF)
S5 Fig. Changes in hepatic T cell phenotype of TLR4-/- mice groups. IHLs at 24 weeks were
stained with anti-CD3, anti-CD4, anti-CD8, anti-TNFα and anti-IFNγ Abs. (A) The absolute
numbers of CD3+ and (B) the absolute number of CD3+CD4+ and CD3+CD8+ cells in liver is
indicated. (C) Percentage of TNFα and IFNγ producing CD4+ or CD8+ T cells in liver are
shown by intracellular staining. IHLs from all groups were cultured in the presence of PMA
plus ionomycin, monensin and brefeldin for 5 h and stained with corresponding antibodies.
The results are expressed as mean ± SEM of more than 4 mice per group from one experiment
representative of three performed.
(TIF)
S6 Fig. The recruitment of B lymphocytes, dendritic cells and NK cells in liver TLR4-/-
animals was not influenced by MFD but it was increased by parasite infection. IHLs from
different groups of mice were stained with anti-CD19, anti-CD11c, anti-CD3, anti-NK1.1. (A)
The absolute numbers of CD19+, (B) the absolute number of CD11chi in liver and (C) the abso-
lute number of NK and NKT cells are indicated. Data are shown as mean ± SEM of more than
3 mice per group from one experiment representative of three performed.
(TIF)
S7 Fig. Protein tyrosine nitration in hepatic tissue and expression of FasL on CD3+ cells in
experimental WT mice. (A) 400x micrographs of hepatic tissue section allow panoramic eval-
uation of protein tirosine nitration after stained with Ab Alexa Fluor 488-anti- nitro tyrosine
(NT). Photographs are representative of one out of five mice. (B) IHL were cultured with
ConA for 48 h and labeled with FITC-anti mouse-CD3 and PE-anti FasL. DNA was stained
with DNA-binding fluorochrome Hoechst 33258 (2 ug/mL). Slides were observed with a
FV1000 (Olympus) confocal microscope. Scale bar: 10 μm.
(TIF)
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